Dectin-1 targeting delivery of TNF-α antisense ODNs complexed with β-1,3-glucan protects mice from LPS-induced hepatitis

Journal of Controlled Release

Volumn 151, Issue 2, 2011, Pages 155-161

  Mochizuki, Shinichi ^a   Sakurai, Kazuo ^a,b  

^a UNIVERSITY OF KITAKYUSHU   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Antisense; Dectin 1; Drug targeting; Shizophyllan

Indexed keywords

ANTIGEN PRESENTING CELLS; ANTISENSE; ANTISENSE OLIGONUCLEOTIDES; ANTISENSE THERAPIES; DECTIN-1; DRUG TARGETING; IN-VIVO; LIPOPOLYSACCHARIDES; NON-TOXICITY; PERITONEAL MACROPHAGE; SCHIZOPHYLLAN; SHIZOPHYLLAN; TUMOR NECROSIS FACTOR ALPHA;

MACROPHAGES; OLIGONUCLEOTIDES;

PHYSIOLOGY;

ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA 1,3 GLUCAN; DECTIN 1; LIPOPOLYSACCHARIDE; SCHIZOPHYLLAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTISENSE THERAPY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GENE DELIVERY SYSTEM; HEPATITIS; IN VIVO STUDY; LONG TERM CARE; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANIMALS; BETA-GLUCANS; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; DRUG-INDUCED LIVER INJURY; HEPATITIS, VIRAL, ANIMAL; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDES, ANTISENSE; PROTECTIVE AGENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79956103959     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.01.026     Document Type: Article

References (39)

1. P.C. Zamecnik, and M.L. Stephenson Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide Proc. Natl Acad. Sci. USA 75 1978 280 284 (Pubitemid 8290783)
2. N.M. Dean, and C.F. Bennett Antisense oligonucleotide-based therapeutics for cancer Oncogene 22 2003 9087 9096 (Pubitemid 38121709)
3. J.H. Chan, S. Lim, and W.S. Wong Antisense oligonucleotides: from design to therapeutic application Clin. Exp. Pharmacol. Physiol. 33 2006 533 540
4. F.M. Coppelli, and J.R. Grandis Oligonucleotides as anticancer agents: from the benchside to the clinic and beyond Curr. Pharm. Des. 11 2005 2825 2840 (Pubitemid 41051869)
5. K.A. Whitehead, R. Langer, and D.G. Anderson Knocking down barriers: advances in siRNA delivery Nat. Rev. Drug Discov. 8 2009 129 138
6. K. Noda, S. Takeuchi, A. Yajima, K. Akiya, T. Kasamatsu, Y. Tomoda, M. Ozawa, K. Sekiba, H. Sugimori, and S. Hashimoto Clinical effect of sizofiran combined with irradiation in cervical cancer patients: a randomized controlled study. Cooperative Study Group on SPG for Gynecological Cancer Jpn J. Clin. Oncol. 22 1992 17 25
7. K. Sakurai, and S. Shinkai Molecular recognition of adenine, cytosine, and uracil in a single-stranded RNA by a natural polysaccharide: schizophyllan J. Am. Chem. Soc. 122 2000 4520 4521 (Pubitemid 30317114)
8. K. Miyoshi, K. Uezu, K. Sakurai, and S. Shinkai Proposal of a new hydrogen-bonding form to maintain curdlan triple helix Chem. Biodivers. 1 2004 916 924
9. K. Sakurai, M. Mizu, and S. Shinkai Polysaccharide-polynucleotide complexes. 2. Complementary polynucleotide mimic behavior of the natural polysaccharide schizophyllan in the macromolecular complex with single-stranded RNA and DNA Biomacromolecules 2 2001 641 650 (Pubitemid 32894618)
10. T. Norisuye, T. Yanaki, and H. Fujita Triple helix of a schizophyllum commune polysaccharide in aqueous solution J. Polym. Sci., Polym. Phys. Ed. 18 1980 547 558 (Pubitemid 10473943)
11. T. Sato, T. Norisuye, and H. Fujita Triple helix of Schizophyllum commune polysaccharide in dilute solution. 5. Light scattering and refractometry in mixtures of water and dimethyl sulfoxide Macromolecules 16 1983 185 189
12. G.D. Brown, and S. Gordon Immune recognition. A new receptor for beta-glucans Nature 413 2001 36 37 (Pubitemid 32843478)
13. P.R. Taylor, G.D. Brown, D.M. Reid, J.A. Willment, L. Martinez-Pomares, S. Gordon, and S.Y. Wong The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages J. Immunol. 169 2002 3876 3882
14. J.A. Willment, H.H. Lin, D.M. Reid, P.R. Taylor, D.L. Williams, S.Y. Wong, S. Gordon, and G.D. Brown Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide J. Immunol. 171 2003 4569 4573 (Pubitemid 37310572)
15. T. Matsumoto, M. Numata, T. Anada, M. Mizu, K. Koumoto, K. Sakurai, T. Nagasaki, and S. Shinkai Chemically modified polysaccharide schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake efficiency Biochim. Biophys. Acta 1670 2004 91 104 (Pubitemid 38115853)
16. Z.A. Cohn, and B. Benson The differentiation of mononuclear phagocytes. Morphology, cytochemistry, and biochemistry J. Exp. Med. 121 1965 153 170
17. A. Kano, M.J. Wolfgang, Q. Gao, J. Jacoby, G.X. Chai, W. Hansen, Y. Iwamoto, J.S. Pober, R.A. Flavell, and X.Y. Fu Endothelial cells require STAT3 for protection against endotoxin-induced inflammation J. Exp. Med. 198 2003 1517 1525 (Pubitemid 37467166)
18. A. Friedman, and D.I. Beller The effect of adherence on the in vitro induction of cytocidal activity by macrophages Immunology 61 1987 469 474 (Pubitemid 17127354)
19. A.R. Thierry, and A. Dritschilo Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity Nucleic Acids Res. 20 1992 5691 5698
20. J. Kurreck Antisense technologies. Improvement through novel chemical modifications Eur. J. Biochem. 270 2003 1628 1644 (Pubitemid 36532522)
21. B. Beutler, N. Krochin, I.W. Milsark, C. Luedke, and A. Cerami Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance Science 232 1986 977 980 (Pubitemid 16085400)
22. E.C. LaCasse, G.G. Cherton-Horvat, K.E. Hewitt, L.J. Jerome, S.J. Morris, E.R. Kandimalla, D. Yu, H. Wang, W. Wang, R. Zhang, S. Agrawal, J.W. Gillard, and J.P. Durkin Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis Clin. Cancer Res. 12 2006 5231 5241 (Pubitemid 44453353)
23. G.D. Brown, J. Herre, D.L. Williams, J.A. Willment, A.S. Marshall, and S. Gordon Dectin-1 mediates the biological effects of beta-glucans J. Exp. Med. 197 2003 1119 1124 (Pubitemid 36570067)
24. V. Lehmann, M.A. Freudenberg, and C. Galanos Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and d-galactosamine- treated mice J. Exp. Med. 165 1987 657 663 (Pubitemid 17059444)
25. H. Matsumoto, S. Tamura, Y. Kamada, S. Kiso, J. Fukushima, A. Wada, N. Maeda, S. Kihara, T. Funahashi, Y. Matsuzawa, I. Shimomura, and N. Hayashi Adiponectin deficiency exacerbates lipopolysaccharide/d-galactosamine-induced liver injury in mice World J. Gastroenterol. 12 2006 3352 3358 (Pubitemid 43933779)
26. P.A. Knolle, and G. Gerken Local control of the immune response in the liver Immunol. Rev. 174 2000 21 34 (Pubitemid 30201376)
27. A. Limmer, J. Ohl, C. Kurts, H.G. Ljunggren, Y. Reiss, M. Groettrup, F. Momburg, B. Arnold, and P.A. Knolle Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance Nat. Med. 6 2000 1348 1354 (Pubitemid 32001018)
28. K. Thompson, J. Maltby, J. Fallowfield, M. McAulay, H. Millward-Sadler, and N. Sheron Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis Hepatology 28 1998 1597 1606 (Pubitemid 28549130)
29. H. Zhang, J. Cook, J. Nickel, R. Yu, K. Stecker, K. Myers, and N.M. Dean Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis Nat. Biotechnol. 18 2000 862 867 (Pubitemid 30640912)
30. L. Dong, L. Zuo, S. Xia, S. Gao, C. Zhang, J. Chen, and J. Zhang Reduction of liver tumor necrosis factor-alpha expression by targeting delivery of antisense oligonucleotides into Kupffer cells protects rats from fulminant hepatitis J. Gene Med. 11 2009 229 239
31. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392 (Pubitemid 17221789)
32. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 41 2001 189 207
33. T.M. Allen Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2 2002 750 763 (Pubitemid 37328910)
34. W.A. Dunn, A.L. Hubbard, and N.N. Aronson Jr. Low temperature selectively inhibits fusion between pinocytic vesicles and lysosomes during heterophagy of 125I-asialofetuin by the perfused rat liver J. Biol. Chem. 255 1980 5971 5978 (Pubitemid 10023606)
35. D.M. Underhill, E. Rossnagle, C.A. Lowell, and R.M. Simmons Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production Blood 106 2005 2543 2550 (Pubitemid 41510832)
36. J. Minari, S. Mochizuki, T. Matsuzaki, Y. Adachi, N. Ohno, and K. Sakurai Enhanced cytokine secretion from primary macrophages due to dectin-1 mediated uptake of CpG DNA/β-1,3-glucan complex Bioconjug. Chem. 22 2011 9 15
37. O. Boussif, F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, and J.P. Behr A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl Acad. Sci. USA 92 1995 7297 7301
38. D. Vergani, K. Choudhuri, D.P. Bogdanos, and G. Mieli-Vergani Pathogenesis of autoimmune hepatitis Clin. Liver Dis. 6 2002 727 737
39. G.D. Martich, R.L. Danner, M. Ceska, and A.F. Suffredini Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents J. Exp. Med. 173 1991 1021 1024